Loading
Ordaos Bio
Ordaos Bio is developing an AI drug discovery pipeline to discover novel immunotherapies in oncology and chronic inflammatory disease.
Funding
Every round, secondary, debt facility or acquisition involving Ordaos Bio that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log in